This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
L01XX Other antineoplastic agents
RX_L01XX
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1989 |
4. Check minimum number of events
Min. number of events
3
|
1989 |
5. Include endpointsNone |
1989 |
6. Filter based on genotype QC (FinnGen only) |
1989 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
L01XX Other antineoplastic agents
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1989 | 977 | 1012 |
| Unadjusted period prevalence (%) | 0.39 | 0.33 | 0.45 |
| Median age at first event (years) | 67.93 | 66.82 | 69.00 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1714
- Matched controls
- 17141
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
230.1
323.0
1421
354
L01XX05
ATC
hydroxycarbamide; oral
3190.2
323.0
1303
16
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
482.4
323.0
692
24
D45
ICD-10 Finland
Polycythaemia vera
277.6
323.0
598
33
D75.2
ICD-10 Finland
Essential thrombocytosis
407.0
323.0
514
18
XW000
NOMESCO Finland
Bone marrow biopsy
21.8
323.0
547
361
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
503.8
266.4
259
6
L01XX35
ATC
anagrelide; oral
+∞
210.9
198
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
387.6
209.8
207
6
TPH00
NOMESCO Finland
Phlebotomy
126.0
206.8
220
20
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
127.9
172.0
183
16
L03AB05
ATC
interferon alfa-2b; parenteral
73.8
152.2
173
26
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
41.2
151.6
191
52
SPAT1074
SPAT
Venesection
132.8
147.9
157
13
L01XX11
ATC
estramustine; systemic
181.1
144.0
149
9
M04AA01
ATC
allopurinol; systemic
4.2
114.3
521
1606
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
30.8
87.8
118
41
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
303.2
85.5
86
*
L03AB04
ATC
interferon alfa-2a; parenteral
135.6
84.8
90
7
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
95.0
81.8
90
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
78.8
404
1323
B99
ICPC
Blood/lymph/spleen disease other
43.6
67.0
83
20
212
Kela drug reimbursment
Gout
9.6
66.0
140
158
174
Kela drug reimbursment
Ruxolitinib
334.3
64.9
65
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
13.4
59.0
105
83
L01XX52
ATC
venetoclax; oral
+∞
57.6
55
*
399
Kela drug reimbursment
Venetoclax
296.2
56.6
57
*
374
Kela drug reimbursment
Ruxolitinib
290.7
55.5
56
*
L01XX28
ATC
[D] imatinib; oral
+∞
55.5
53
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
90.4
55.2
61
7
189
Kela drug reimbursment
Imatinib
98.2
52.1
57
6
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
39.7
51.6
65
17
WW500
NOMESCO Finland
Blood transfusion
5.1
48.9
164
349
L01XE18
ATC
[U] ruxolitinib; oral
230.9
44.1
45
*
L01EJ01
ATC
ruxolitinib; oral
225.6
43.1
44
*
1518
Kela drug reimbursment
NA
+∞
41.8
40
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
41.3
231
778
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
14.9
41.0
69
48
L01XE01
ATC
[U] imatinib; oral
112.8
40.9
44
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
48.2
39.0
47
10
A04AA01
ATC
ondansetron; systemic, rectal
3.4
36.4
192
616
116
Kela drug reimbursment
Prostate cancer
3.3
36.3
197
646
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
129.4
35.8
38
*
L01XX47
ATC
[U] idelalisib; oral
+∞
35.5
34
*
372
Kela drug reimbursment
Idelalisib
354.2
35.1
35
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.5
33.6
48
21
L01XX50
ATC
[U] ixazomib; oral
+∞
33.4
32
*
L03AA02
ATC
filgrastim; parenteral
5.0
33.2
110
230
7512
FHL
Orchidectomy (bilateral)
64.7
33.1
38
6
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
10.2
33.0
66
67
B03XA02
ATC
darbepoetin alfa; parenteral
6.0
30.5
86
149
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
30.3
29
*
L01XE27
ATC
[U] ibrutinib; oral
69.2
30.0
34
5
1505
Kela drug reimbursment
Ixazomib
108.6
29.7
32
*
B01AB05
ATC
enoxaparin; parenteral
1.9
29.7
609
3880
398
Kela drug reimbursment
Ixazomib
105.2
28.7
31
*
L01XX46
ATC
[U] olaparib; oral
+∞
28.2
27
*
B01AC14
ATC
[U] anagrelide; oral
+∞
28.2
27
*
B74
ICPC
Malignant neoplasm blood other
31.5
28.2
37
12
390
Kela drug reimbursment
Ibrutinib
39.7
28.1
35
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
28.0
157
524
1512
Kela drug reimbursment
Ibrutinib
43.3
27.8
34
8
1511
Kela drug reimbursment
Olaparib
147.4
27.7
29
*
L03AA04
ATC
NA
32.4
26.9
35
11
389
Kela drug reimbursment
Olaparib
142.2
26.7
28
*
1510
Kela drug reimbursment
Niraparib
142.2
26.7
28
*
3009
Kela drug reimbursment
Niraparib
142.2
26.7
28
*
L01XX54
ATC
[U] niraparib; oral
264.4
25.8
26
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.7
25.7
43
30
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
24.9
834
6110
R50.9
ICD-10 Finland
Fever, unspecified
2.2
24.6
274
1354
ZX120
NOMESCO Finland
Intravenous
2.4
24.3
215
948
B28
ICPC
Limited function/disability (B)
13.4
24.2
42
32
C90.0
ICD-10 Finland
Multiple myeloma
7.1
23.8
59
86
L02BB03
ATC
bicalutamide; oral
3.8
23.8
104
286
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.9
23.5
67
118
L01BB05
ATC
fludarabine; systemic
47.4
23.4
28
6
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
84.6
22.7
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
21.7
244
1207
L02BB01
ATC
flutamide; oral
23.5
21.3
30
13
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.2
21.2
236
1158
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.7
21.1
73
161
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.6
20.9
54
84
L01XX23
ATC
mitotane; oral
+∞
20.9
20
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
11.7
20.8
38
33
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
19.9
172
747
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.2
19.7
224
1110
B01AB10
ATC
tinzaparin; parenteral
2.6
19.5
154
636
1507
Kela drug reimbursment
Pomalidomide
31.7
19.3
25
8
393
Kela drug reimbursment
Pomalidomide
28.2
18.7
25
9
L01XK02
ATC
niraparib; oral
101.1
18.6
20
*
L01XK01
ATC
olaparib; oral
192.0
18.6
19
*
D73.5
ICD-10 Finland
Infarction of spleen
44.5
18.3
22
5
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
22.0
18.2
26
12
316
Kela drug reimbursment
Imatinib
53.1
18.0
21
*
L04AX06
ATC
pomalidomide; oral
27.0
17.8
24
9
D75.0
ICD-10 Finland
Familial erythrocytosis
24.3
17.3
24
10
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.0
17.3
104
364
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
7.6
17.2
40
54
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
13.4
17.0
29
22
G03HA01
ATC
cyproterone; systemic
9.6
16.9
34
36
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
91.0
16.6
18
*
L01XX17
ATC
[U] topotecan; systemic
91.0
16.6
18
*
B04
ICPC
Blood symptom/complaint
12.4
15.9
28
23
L04AX04
ATC
lenalidomide; oral
8.8
15.7
33
38
L01AB01
ATC
busulfan; systemic
161.4
15.5
16
*
153
Kela drug reimbursment
Lenalidomid
8.0
15.3
34
43
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
15.3
220
1196
H02AB09
ATC
hydrocortisone; systemic
4.4
15.3
55
128
B03XA01
ATC
erythropoietin; parenteral
6.5
15.2
39
61
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
14.7
359
2323
TPH00
SPAT
NA
151.2
14.5
15
*
N02AA05
ATC
oxycodone; systemic
1.8
14.1
292
1796
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
13.6
13
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
11.0
13.5
25
23
128
Kela drug reimbursment
Cancers of female genital organs
4.2
13.5
51
125
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
16.3
13.5
21
13
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
13.4
190
1025
ZX112
NOMESCO Finland
Subcutaneous
3.6
13.4
59
166
S97
ICPC
Chronic ulcer skin
2.3
13.2
121
540
L02AE03
ATC
goserelin; implant
4.9
13.1
42
87
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.0
13.1
51
129
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
11.0
13.0
24
22
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
19.2
12.9
19
10
B75
ICPC
Neoplasm blood benign/unspecified
70.4
12.6
14
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.2
12.5
18
9
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
37.8
12.2
15
*
ZX108
NOMESCO Finland
Inhalation
7.6
11.9
27
36
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
11.9
102
444
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
11.6
115
534
D75.1
ICD-10 Finland
Secondary polycythaemia
7.2
11.5
27
38
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
+∞
11.5
11
*
B73
ICPC
Leukaemia
17.2
11.2
17
10
H02AB02
ATC
dexamethasone; systemic
1.8
11.2
189
1086
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
11.2
483
3569
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
11.0
349
2401
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
7.4
11.0
25
34
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.4
10.9
92
396
L03AA13
ATC
pegfilgrastim; parenteral
2.6
10.9
80
321
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
10.9
80
321
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.3
10.6
51
156
Z51.5
ICD-10 Finland
Palliative care
2.0
10.4
126
641
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
12.1
10.3
18
15
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13.2
10.2
17
13
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
13.2
10.2
17
13
J05AB11
ATC
valaciclovir; oral
1.7
10.2
199
1199
N02AX02
ATC
tramadol; systemic, rectal
1.4
10.0
688
5536
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
9.9
373
2667
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
26.2
9.8
13
5
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
26.2
9.8
13
5
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
9.8
103
493
WW300
NOMESCO Finland
Transfer of autologic stem cells
9.6
9.8
19
20
A10BA02
ATC
metformin; oral
0.7
9.7
263
3725
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
9.6
132
704
KFC10
NOMESCO Finland
Bilateral orchiectomy
6.8
9.6
23
34
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
9.5
64
245
WW200
NOMESCO Finland
Immunization
3.0
9.4
54
185
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
100.6
9.4
10
*
L01AA04
ATC
NA
100.6
9.4
10
*
329
Kela drug reimbursment
Lenalidomide
8.1
9.3
20
25
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
9.3
183
1101
C03CA01
ATC
furosemide; systemic
1.4
9.3
562
4405
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
5.1
9.3
28
56
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.7
9.1
22
33
JN4BD
NOMESCO Finland
Extensive body CT
1.7
9.1
207
1305
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
24.1
8.9
12
5
150
Kela drug reimbursment
Dasatinib
50.2
8.7
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.6
219
1417
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.7
8.5
36
100
7461
FHL
Needle biopsy in the operating room
7.0
8.5
20
29
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.5
8.3
61
246
XQ848
NOMESCO Finland
Dermatological photography
2.8
8.3
52
190
WW409
NOMESCO Finland
Other aferesis
14.5
8.2
13
9
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
6.5
8.2
20
31
JAL30
NOMESCO Finland
Omentectomy
4.1
8.2
30
74
1XC02
NOMESCO Finland
NA
5.7
8.1
22
39
L01AA02
ATC
chlorambucil; oral
8.2
8.1
17
21
6BA02
NOMESCO Finland
NA
10.1
8.0
15
15
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
22.1
8.0
11
5
L01EL01
ATC
ibrutinib; oral
22.1
8.0
11
5
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
8.0
156
938
306
Kela drug reimbursment
Erythropoietin and darbepoetin
7.3
8.0
18
25
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.9
7.9
46
162
J01MA12
ATC
levofloxacin; systemic
1.5
7.8
317
2286
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.7
7.8
25
54
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
7.8
261
3571
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.7
413
3149
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.6
7.7
118
1897
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
7.6
110
600
L02AA02
ATC
polyestradiol phosphate; parenteral
25.1
7.6
10
*
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.3
7.6
70
317
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
10.1
7.5
14
14
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.1
7.5
39
129
A02BC02
ATC
pantoprazole; systemic
1.3
7.5
1023
9036
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
80.4
7.4
8
*
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
80.4
7.4
8
*
L01EM01
ATC
idelalisib; oral
80.4
7.4
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
7.4
181
1160
I81
ICD-10 Finland
Portal vein thrombosis
7.3
7.2
16
22
R04.0
ICD-10 Finland
Epistaxis
1.7
7.2
135
802
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.0
7.2
84
423
JN4AD
NOMESCO Finland
Body CT examination
1.7
7.1
135
806
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
7.1
92
483
B01AA03
ATC
warfarin; systemic
1.4
7.1
375
2848
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.0
7.0
26
66
L01AA01
ATC
cyclophosphamide; systemic
5.5
6.9
19
35
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.9
256
1812
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.7
6.9
28
77
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
40.2
6.8
8
*
L01XE06
ATC
[U] dasatinib; systemic
40.2
6.8
8
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
6.7
57
250
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
6.7
139
855
L57.0
ICD-10 Finland
Actinic keratosis
1.6
6.6
185
1227
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.6
6.6
46
181
D69.5
ICD-10 Finland
Secondary thrombocytopenia
8.7
6.6
13
15
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
6.5
188
1256
K93
ICPC
Pulmonary embolism
3.8
6.5
25
66
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.4
6.4
50
211
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
7.4
6.4
14
19
1XX32
NOMESCO Finland
NA
14.4
6.4
10
7
J01MA14
ATC
moxifloxacin; systemic
1.6
6.3
142
890
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.6
6.3
43
170
L71.9
ICD-10 Finland
Rosacea, unspecified
2.8
6.3
37
133
M10.4
ICD-10 Finland
Other secondary gout
18.1
6.3
9
5
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
18.1
6.3
9
5
1AA09
NOMESCO Finland
NA
18.1
6.3
9
5
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
+∞
6.3
6
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
6.3
6
*
PH_2
NOMESCO Finland
Other procedures on veins
+∞
6.3
6
*
L01XG03
ATC
ixazomib; oral
26.8
6.2
8
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.7
6.2
25
69
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.1
538
4415
1XC07
NOMESCO Finland
NA
7.7
6.1
13
17
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.0
6.1
22
55
BCA30
NOMESCO Finland
Unilateral adrenalectomy
12.6
6.1
10
8
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
12.6
6.1
10
8
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
8.6
6.1
12
14
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
6.0
228
3069
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1441
2134
21.88
307.65
12.9
3.6
286.93
248.30
u/l
8.89
1400
2005
512
274
24.82
307.65
1.2
1.2
31.95
50.13
u/l
0.70
418
234
978
2218
7.71
307.65
5.3
2.4
1.92
1.81
%
2.54
871
1961
496
311
20.91
307.65
1.5
1.6
—
—
—
0
0
842
1672
8.00
307.65
5.4
2.5
76.11
69.17
e9/l
4.94
639
1291
510
149
45.69
307.65
1.0
1.0
—
—
—
0
0
1225
4526
5.44
306.83
6.8
2.8
1016.80
6533.43
umol/l
9.62
1149
3834
1579
7357
6.56
293.41
20.4
5.8
1.02
0.65
%
51.30
1538
6816
601
1259
6.41
289.00
12.2
3.7
0.85
0.55
%
2.01
262
306
1593
7545
6.58
288.18
20.8
5.8
2.34
2.83
%
21.65
1554
6977
1592
7574
6.52
285.28
22.0
6.0
8.39
8.94
%
7.73
1552
7032
1595
7706
6.40
277.29
21.4
5.9
25.44
26.54
%
2.66
1555
7115
1576
7572
6.21
274.78
19.2
5.7
60.55
58.09
%
10.26
1534
7022
1623
8002
6.59
273.99
18.2
5.5
0.64
0.61
e9/l
0.64
1527
6787
1626
8033
6.61
273.72
18.3
5.5
0.07
0.04
e9/l
39.80
1529
6831
1630
8177
6.50
266.07
18.6
5.6
2.18
1.89
e9/l
1.17
1549
7088
1641
8301
6.58
264.52
20.4
5.7
0.20
0.19
e9/l
0.29
1545
7172
574
1321
5.70
246.00
12.7
4.0
0.18
0.12
%
1.17
312
395
1673
9423
5.88
213.28
30.3
8.8
5.17
4.21
e9/l
10.34
1603
8142
739
2464
4.18
193.86
2.7
2.6
22.77
22.03
%
0.62
634
2098
751
2621
4.00
183.12
2.6
2.5
2.35
2.28
g/l
2.16
718
2420
772
2825
3.83
174.27
2.7
2.5
12.91
12.33
umol/l
1.31
739
2616
231
297
8.67
171.39
9.5
3.4
1.43
1.46
%
0.04
184
228
271
442
6.94
162.68
3.4
2.2
3.34
3.56
g/l
1.53
257
413
390
919
5.03
157.74
2.3
1.8
1.06
1.55
g/l
20.27
341
796
1491
9053
3.58
137.61
13.3
6.3
11.86
11.95
umol/l
0.09
1458
8574
250
488
5.72
124.07
2.2
1.6
—
—
—
0
0
152
188
8.67
115.61
10.0
3.2
62.48
56.82
%
1.29
96
123
183
306
6.49
106.18
6.7
5.3
316.90
903.64
iu/ml
0.74
31
47
221
447
5.44
105.01
3.1
2.0
94.16
87.53
%
3.85
191
431
1130
6520
2.70
100.92
4.0
2.8
175.88
152.12
ug/l
1.38
1055
5894
174
315
5.96
92.94
6.3
3.3
61.91
58.27
%
2.03
174
315
1166
7110
2.55
88.56
26.5
10.1
0.07
0.00
e9/l
3.23
1076
5738
136
240
6.01
74.35
2.5
2.5
207.33
1247.32
u/ml
—
9
19
1327
9021
2.42
73.06
11.8
6.8
1.21
1.21
mmol/l
0.40
1132
7554
1221
8257
2.24
64.32
9.7
6.0
1.22
1.21
mmol/l
2.13
1123
7397
170
414
4.40
63.97
3.8
2.2
179.58
203.19
%
2.55
163
393
516
2441
2.50
63.85
7.2
5.4
1.10
1.03
mmol/l
6.35
491
2226
803
4624
2.24
62.86
2.6
2.2
5.28
3.05
mg/l
17.45
702
3902
316
1180
2.99
62.07
5.6
2.7
9.17
10.69
g/l
4.28
296
1065
99
152
6.80
61.98
2.2
2.0
3.56
4.33
mg/l
1.47
99
146
1666
13024
2.72
60.61
20.4
7.7
84.44
80.00
u/l
3.58
1629
12187
41
16
26.14
58.96
1.1
1.0
—
—
—
0
0
774
4524
2.16
57.05
1.9
1.6
20.60
20.48
nmol/l
0.07
697
3789
77
106
7.52
53.18
2.3
1.4
—
—
—
0
0
77
106
7.52
53.18
2.3
1.4
—
—
—
0
0
554
2933
2.23
51.42
4.5
3.2
0.82
0.81
mmol/l
1.37
529
2721
727
4306
2.08
50.32
6.2
4.0
84.15
86.18
%
1.26
684
4207
367
1651
2.50
49.33
4.8
2.8
65.12
66.43
g/l
2.28
338
1499
1094
7601
1.98
47.32
2.4
2.1
89.82
93.83
pmol/l
2.25
693
3861
527
2819
2.18
47.08
3.1
2.0
31.54
29.94
s
5.09
493
2733
65
88
7.60
45.52
3.1
2.0
2117.31
720.07
e6/l
0.40
29
40
394
1893
2.35
45.45
5.1
2.6
7.14
9.41
umol/l
1.60
359
1672
66
94
7.23
44.20
2.8
2.7
27.75
39.67
%
1.77
20
35
145
420
3.65
42.65
3.6
2.9
1.40
1.71
mg/l
4.60
137
377
47
9
53.42
39.64
4.7
5.2
—
—
—
0
0
141
426
3.49
38.86
3.0
1.5
—
—
—
0
0
137
413
3.49
37.88
3.1
1.5
—
—
—
0
0
1071
7823
1.80
35.36
7.6
4.8
35.05
34.79
g/l
0.81
1014
7245
1314
10243
1.83
34.49
6.4
4.9
6.56
6.85
mmol/l
7.76
1275
9656
570
3462
1.91
34.10
2.6
1.6
1.26
1.47
mg/l
0.84
443
2715
57
95
6.15
32.89
6.2
3.7
—
—
—
0
0
52
80
6.65
32.43
3.1
1.8
0.23
0.23
e9/l
0.01
44
71
221
945
2.51
32.39
2.2
1.9
1.16
1.59
g/l
2.04
190
846
38
7
55.29
32.33
1.4
1.0
—
—
—
0
0
52
82
6.48
31.67
3.1
1.9
1408.76
571.23
e6/l
0.56
41
71
172
664
2.74
30.97
7.8
3.5
43.81
58.41
mg/l
0.78
156
547
168
643
2.76
30.75
7.4
3.5
5.69
1.73
ratio
0.42
18
50
106
311
3.54
30.51
3.3
1.6
—
—
—
0
0
171
665
2.72
30.35
7.8
3.5
45.74
81.60
mg/l
0.86
156
550
584
3737
1.80
28.70
1.9
1.8
1085.55
1174.50
nmol/l
1.57
437
2787
185
788
2.49
27.21
3.8
2.6
3.26
3.83
g/l
5.83
130
571
503
3121
1.82
27.16
2.8
1.9
—
—
—
0
0
185
789
2.48
27.14
3.8
2.6
6.60
7.48
g/l
10.34
135
591
185
789
2.48
27.14
3.8
2.6
—
—
—
0
0
35
42
8.46
27.04
1.2
1.4
—
—
—
0
0
174
733
2.51
26.18
3.8
2.7
3.11
3.15
g/l
0.18
130
584
50
95
5.37
25.18
1.8
1.8
13.33
16.36
%
0.41
15
33
173
743
2.45
24.96
3.9
2.6
10.32
10.50
g/l
0.16
141
633
83
237
3.61
24.89
1.2
1.2
—
—
—
0
0
161
674
2.51
24.53
4.4
2.7
1.60
1.20
g/l
0.44
145
583
49
95
5.26
24.14
1.7
1.8
—
—
—
0
0
37
55
6.84
23.82
1.8
2.5
330.00
39899.25
u/ml
—
5
12
146
593
2.58
23.68
3.7
2.5
0.00
0.02
g/l
1.36
135
546
57
128
4.56
23.67
1.7
1.7
—
—
—
0
0
79
233
3.49
22.57
1.2
1.4
109.43
130.89
u/ml
0.52
14
42
254
1340
2.03
22.06
2.2
1.6
—
—
—
0
0
91
301
3.12
21.63
1.8
1.4
—
—
—
0
0
30
40
7.60
21.24
4.1
1.7
—
—
—
0
0
980
7636
1.56
20.45
13.5
10.6
1.38
1.32
inr
1.14
314
2090
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
152
680
2.34
19.97
3.7
2.7
0.33
0.35
u/ml
0.45
101
399
131
553
2.47
19.58
3.7
2.5
0.00
0.00
g/l
0.00
121
515
63
176
3.66
19.55
4.3
1.4
—
—
—
0
0
132
560
2.45
19.51
3.7
2.5
0.00
0.00
g/l
0.00
121
516
142
623
2.38
19.49
3.6
2.4
38.56
37.33
g/l
1.57
127
537
65
188
3.54
19.16
4.3
1.4
—
—
—
0
0
75
241
3.19
18.73
1.7
1.4
—
—
—
0
0
38
74
5.22
18.66
5.8
1.4
—
—
—
0
0
38
74
5.22
18.66
5.8
1.4
—
—
—
0
0
33
57
5.87
18.39
1.5
1.4
—
—
—
0
0
38
75
5.15
18.38
5.9
1.4
—
—
—
0
0
65
197
3.38
17.85
1.8
1.7
—
—
—
0
0
1415
12165
1.57
17.56
5.7
4.3
13.65
13.99
mm/h
0.30
1319
11144
42
94
4.54
17.55
5.4
1.4
—
—
—
0
0
42
94
4.54
17.55
5.4
1.4
—
—
—
0
0
42
94
4.54
17.55
5.4
1.4
—
—
—
0
0
42
94
4.54
17.55
5.4
1.4
—
—
—
0
0
69
224
3.16
16.97
1.2
1.2
367.89
289.17
u/ml
0.60
36
127
35
69
5.15
16.96
1.2
1.2
—
—
—
0
0
48
123
3.97
16.85
1.5
1.3
—
—
—
0
0
345
2181
1.70
16.55
2.1
1.8
—
—
—
0
0
18
17
10.68
16.44
1.3
1.2
77.50
71.40
%
—
8
5
342
2173
1.69
16.06
2.2
1.8
—
—
—
0
0
75
265
2.90
15.94
2.0
1.4
—
—
—
0
0
68
231
3.01
15.50
1.9
1.4
—
—
—
0
0
971
7867
1.46
14.93
7.7
4.1
—
—
—
0
0
52
155
3.42
14.69
4.8
1.4
—
—
—
0
0
52
155
3.42
14.69
4.8
1.4
—
—
—
0
0
52
155
3.42
14.69
4.8
1.4
—
—
—
0
0
669
5063
1.48
14.50
5.6
3.2
31.17
35.32
u/l
1.21
638
4794
274
1683
1.73
14.47
5.9
6.8
10.39
10.60
mmol/l
0.18
258
1592
254
1527
1.76
14.47
4.2
3.9
1.22
1.23
mmol/l
2.04
219
1325
60
198
3.09
14.39
3.1
2.7
—
—
—
0
0
241
1440
1.77
14.01
3.3
2.2
417.40
372.52
nmol/l
2.13
222
1300
23
37
6.28
13.75
1.5
1.3
—
—
—
0
0
84
341
2.53
13.68
1.1
1.2
—
—
—
0
0
68
248
2.80
13.67
1.9
1.6
—
—
—
0
0
52
166
3.19
13.20
1.0
1.1
—
—
—
0
0
567
4231
1.48
12.89
5.2
2.4
—
—
—
0
0
54
179
3.07
12.88
1.1
1.2
2.23
4.65
u/ml
0.63
22
54
119
581
2.11
12.64
1.7
1.2
—
—
—
0
0
13
11
11.89
12.64
1.3
1.5
—
—
—
0
0
21
35
6.05
12.13
1.3
1.1
68.36
85.16
%
1.17
11
19
26
55
4.78
11.66
1.2
1.2
—
—
—
0
0
49
164
3.04
11.53
1.0
1.1
112.91
115.11
%
0.21
44
149
741
5908
1.41
11.46
3.5
3.1
2203.29
1612.87
ng/l
1.21
654
5112
150
833
1.87
11.06
2.5
1.9
1.35
2.22
ug/l
0.59
133
728
20
35
5.76
11.01
1.3
1.6
77.82
84.55
%
0.25
11
20
23
47
4.94
10.74
1.5
1.6
—
—
—
0
0
385
2745
1.50
10.72
2.3
1.5
2.03
2.64
g/l
6.44
246
1557
197
1200
1.71
10.64
1.8
1.7
—
—
—
0
0
89
418
2.18
10.47
1.4
1.5
—
—
—
0
0
760
6158
1.38
10.40
4.0
3.4
2.33
2.35
mmol/l
3.20
664
5260
1416
12680
1.41
10.34
47.7
20.2
15.69
13.85
%
118.95
1409
12347
29
74
3.96
10.31
2.4
2.6
2211.10
1395.15
u/ml
0.69
29
74
124
673
1.90
9.83
3.5
2.6
—
—
—
0
0
30
85
3.57
9.23
2.6
1.4
—
—
—
0
0
30
85
3.57
9.23
2.6
1.4
—
—
—
0
0
20
42
4.80
9.06
1.7
1.3
—
—
—
0
0
935
7951
1.33
8.88
5.1
5.4
0.00
0.00
estimate
0.00
247
1500
46
173
2.70
8.83
1.1
1.2
4.84
5.08
u/ml
0.03
19
78
60
257
2.38
8.81
1.4
1.4
2056.50
1525.02
e6/l
0.53
42
185
1697
15845
1.48
8.71
34.1
16.5
21.09
26.22
mg/l
10.00
1487
12838
36
119
3.06
8.71
2.3
1.3
—
—
—
0
0
55
228
2.45
8.67
1.4
1.4
152616.45
73106.75
e6/l
0.46
33
134
943
8055
1.32
8.57
4.0
4.0
0.00
0.00
estimate
0.80
254
1458
85
425
2.04
8.56
1.3
1.6
0.22
0.24
g/l
0.76
77
405
63
280
2.29
8.52
1.3
1.5
31.93
31.78
g/l
0.04
51
254
63
280
2.29
8.52
1.3
1.3
—
—
—
0
0
135
789
1.76
8.45
4.0
1.9
—
—
—
0
0
87
441
2.02
8.44
1.3
1.5
1.10
1.18
g/l
1.75
80
420
126
725
1.79
8.32
2.4
1.8
—
—
—
0
0
47
187
2.55
8.09
1.3
1.4
240.47
278.42
pmol/l
0.34
34
149
14
24
5.87
7.85
15.8
3.6
—
—
—
0
0
827
6994
1.31
7.84
4.3
4.1
42.71
125.36
ng/l
0.75
681
5307
81
412
2.01
7.81
2.0
2.0
17.73
12.26
mg/l
1.20
72
375
33
112
2.98
7.67
1.4
1.2
—
—
—
0
0
656
5387
1.32
7.62
3.1
2.5
52.02
58.38
u/l
5.11
605
4939
922
7933
1.30
7.62
4.0
4.0
0.00
0.00
estimate
0.00
255
1490
34
119
2.89
7.49
2.4
1.3
—
—
—
0
0
611
4978
1.33
7.48
3.5
3.3
0.50
0.50
e6/l
0.02
485
3835
13
22
5.94
7.38
1.6
1.8
—
—
—
0
0
15
30
5.03
7.18
1.3
1.0
—
—
—
0
0
653
5407
1.31
7.03
3.5
3.4
66.23
88.83
e6/l
0.33
524
4236
455
3600
1.34
6.69
4.2
4.0
643.54
618.83
ng/l
0.02
384
3062
138
867
1.64
6.66
2.9
3.2
4.25
4.39
pmol/l
1.12
112
749
11
18
6.14
6.43
1.6
1.5
—
—
—
0
0
230
1634
1.46
6.37
6.3
6.6
1.34
1.39
mmol/l
0.30
223
1570
37
148
2.53
6.37
1.9
1.6
—
—
—
0
0
51
236
2.19
6.34
6.2
6.9
12.07
12.54
mg/l
0.33
45
221
12
22
5.48
6.29
1.0
2.0
—
—
—
0
0
729
6193
1.28
6.28
4.1
3.9
132.87
117.83
e6/l
0.16
550
4534
242
1742
1.44
6.26
3.8
3.4
5.73
5.83
kpa
0.75
232
1686
171
1148
1.54
6.24
4.0
3.6
1.50
1.95
mmol/l
0.69
117
862
179
1214
1.52
6.23
4.0
3.7
4.97
5.16
kpa
2.28
161
1125
134
851
1.62
6.21
4.3
3.6
23.82
24.14
mmol/l
0.57
128
763
240
1734
1.44
6.08
3.9
3.5
1.48
2.05
mmol/l
1.47
189
1379
1238
11242
1.27
6.00
5.2
4.9
7254.50
1735.09
e6/l
—
8
181
475
3839
1.31
5.94
2.8
2.7
4.25
5.29
e6/l
1.66
436
3368
39
167
2.36
5.83
1.3
1.2
44.62
50.78
u/l
0.48
26
120
108
668
1.65
5.58
1.8
1.8
40.14
38.56
u/l
0.28
90
577
9
7
12.91
5.58
2.0
2.0
1.83
1.71
%
—
9
7
18
52
3.48
5.45
2.5
1.6
—
—
—
0
0
25
89
2.83
5.41
3.6
3.9
—
—
—
0
0
198
1413
1.45
5.37
4.2
2.9
56.17
61.22
ml/min/173m2
1.68
125
590
438
3552
1.30
5.28
4.1
3.1
2.45
2.46
mmol/l
0.86
387
3121
489
5862
0.78
5.28
3.6
4.0
12.54
8.21
mg/mmol
1.28
310
3662
234
1727
1.40
5.26
1.9
2.1
0.20
0.20
g/l
0.89
211
1610
644
5507
1.25
4.99
2.3
2.2
141.99
226.23
u/l
3.60
600
5137
72
414
1.77
4.88
1.5
1.3
—
—
—
0
0
72
414
1.77
4.88
1.5
1.3
—
—
—
0
0
32
137
2.36
4.84
1.1
1.0
—
—
—
0
0
473
5637
0.79
4.76
3.0
3.2
6.89
7.13
mmol/l
0.47
390
4652
72
419
1.75
4.70
2.7
2.5
15.50
15.85
%
0.24
40
207
77
460
1.70
4.59
1.5
1.6
0.84
13.49
iu/ml
0.53
12
100
25
98
2.57
4.55
1.8
1.5
—
—
—
0
0
44
222
2.00
4.47
2.7
1.4
—
—
—
0
0
44
222
2.00
4.47
2.7
1.4
—
—
—
0
0
15
44
3.43
4.47
1.1
1.3
—
—
—
0
0
44
224
1.99
4.37
2.7
1.4
—
—
—
0
0
44
224
1.99
4.37
2.7
1.4
—
—
—
0
0
469
5548
0.80
4.35
3.3
3.3
1722.75
277.00
mg/l
2.73
295
3494
44
225
1.98
4.32
2.7
1.4
—
—
—
0
0
282
2213
1.32
4.28
7.2
7.1
12.29
11.97
kpa
0.34
271
2108
282
2213
1.32
4.28
7.2
7.1
4.88
5.08
kpa
3.25
271
2110
153
1087
1.44
4.28
1.6
1.5
—
—
—
0
0
356
2883
1.29
4.28
3.1
3.1
1.53
2.15
e6/l
1.41
183
1635
518
4387
1.24
4.27
4.5
4.4
0.00
0.00
estimate
0.50
242
1431
255
1976
1.33
4.23
7.6
7.4
95.55
95.37
%
0.19
248
1905
44
227
1.96
4.22
2.7
1.4
—
—
—
0
0
21
79
2.68
4.16
1.4
5.1
—
76.20
—
0
15
112
754
1.51
4.11
23.7
3.9
38.92
68.12
u/ml
1.57
112
726
1047
9544
1.20
4.09
4.0
3.2
63.17
54.62
u/l
1.74
988
8702
24
98
2.47
4.05
1.9
1.5
—
—
—
0
0
23
92
2.52
4.05
4.1
2.0
—
—
—
0
0
280
2213
1.31
4.04
7.3
7.1
0.95
1.15
mmol/l
0.30
211
1722
64
381
1.70
3.91
2.3
1.4
—
—
—
0
0
1564
14862
1.24
3.87
5.3
4.3
1.33
1.28
mmol/l
0.84
1466
13237
768
6825
1.20
3.87
2.4
2.2
78.42
79.00
nmol/l
0.22
682
5932
6
5
12.03
3.76
1.0
1.0
—
—
—
0
0
26
115
2.28
3.71
1.8
1.4
—
—
—
0
0
67
416
1.63
3.52
1.7
1.6
—
—
—
0
0
9
17
5.31
3.51
1.3
1.2
—
—
—
0
0
106
734
1.47
3.44
4.7
4.0
24.32
24.86
mmol/l
0.96
92
676
205
1589
1.32
3.41
2.4
2.3
32.70
37.79
u/l
1.20
183
1356
77
499
1.56
3.41
1.9
1.7
—
—
—
0
0
1447
13703
1.21
3.38
40.8
18.0
37.98
38.77
%
2.02
892
8610
225
1770
1.31
3.37
3.4
3.0
205.35
225.19
ng/l
0.36
210
1615
858
7769
1.18
3.37
2.7
2.4
—
—
—
0
0
20
84
2.39
3.23
1.1
1.1
53.69
28.55
u/l
1.05
13
56
20
84
2.39
3.23
1.1
1.1
141.67
83.35
u/l
1.18
12
59
77
506
1.54
3.22
3.1
3.2
24.65
25.20
mmol/l
0.49
70
437
36
192
1.89
3.20
1.1
1.3
270.00
275.91
mosm/kgh2o
0.99
30
136
185
1428
1.33
3.18
3.3
2.8
4.30
4.54
kpa
1.02
179
1377
37
202
1.85
3.08
2.6
3.5
—
—
—
0
0
1279
12023
1.18
3.07
4.4
4.0
15.16
15.03
pmol/l
1.02
1163
10687
10
29
3.46
3.05
1.2
1.0
—
—
—
0
0
227
1814
1.28
3.03
8.2
7.9
113.84
120.42
g/l
4.23
219
1751
136
1010
1.37
3.02
9.0
8.9
23.85
24.36
mmol/l
0.78
130
949
137
1019
1.37
3.02
8.6
10.1
—
—
—
0
0
48
780
0.61
3.01
2.0
1.8
—
—
—
0
0
111
798
1.41
2.99
4.9
5.4
1.77
1.58
%
1.31
104
749
19
81
2.36
2.98
1.3
1.2
—
—
—
0
0
5
5
10.02
2.98
3.4
1.0
—
—
—
0
0
674
6038
1.18
2.91
4.3
4.3
—
—
—
0
0
100
714
1.42
2.81
2.1
3.3
14.40
5794.27
u/ml
0.86
83
607
38
216
1.77
2.81
1.5
1.4
—
—
—
0
0
28
144
1.96
2.80
1.1
1.1
—
—
—
0
0
69
460
1.52
2.75
1.3
1.1
—
—
—
0
0
51
318
1.62
2.71
1.3
1.4
—
—
—
0
0
108
789
1.39
2.68
5.0
5.5
0.93
0.89
%
0.44
101
742
69
467
1.49
2.58
1.3
1.1
—
—
—
0
0
16
68
2.36
2.55
1.3
2.0
4114.00
28114.88
e6/l
0.46
11
41
7
16
4.39
2.47
1.0
1.1
—
—
—
0
0
310
3632
0.83
2.47
2.9
3.3
0.78
0.78
ug/l
0.01
215
2587
357
3070
1.20
2.44
3.0
2.9
1.19
1.30
e6/l
0.15
188
1812
1560
15018
1.18
2.40
33.7
15.7
73.60
74.41
ml/min/173m2
0.89
1398
12450
5
8
6.26
2.37
2.8
4.8
—
—
—
0
0
16
71
2.26
2.34
1.2
1.1
—
—
—
0
0
21
105
2.01
2.31
1.6
1.6
1.18
7.33
u/l
2.63
11
58
67
463
1.46
2.29
1.4
1.8
—
—
—
0
0
1725
16777
1.21
2.25
35.3
19.6
139.39
139.65
mmol/l
3.71
1705
16322
18
86
2.10
2.23
1.3
1.6
6.19
7.67
u/l
0.33
13
74
309
2646
1.20
2.22
32.0
28.0
1.56
1.40
inr
0.83
38
357
16
74
2.17
2.14
1.6
1.3
—
—
—
0
0
17
81
2.11
2.12
1.0
1.0
—
—
—
0
0
10
37
2.71
2.10
2.7
1.8
1.29
1.52
ug/l
—
10
32
232
1943
1.22
2.10
4.5
3.7
—
—
—
0
0
16
76
2.11
2.02
1.3
2.1
977.00
886.43
e6/l
0.09
11
61
61
426
1.45
2.01
2.5
2.2
124.29
127.59
g/l
0.40
52
308
47
311
1.52
2.01
1.6
1.5
381.45
298.18
pmol/l
0.30
47
306
177
1448
1.24
2.01
3.0
3.7
85.96
93.19
ng/l
0.65
158
1233
1725
16813
1.20
1.99
38.0
19.8
4.03
3.99
mmol/l
6.90
1702
16330
6
16
3.76
1.93
1.0
1.2
—
—
—
0
0
29
172
1.70
1.93
1.1
1.1
—
—
—
0
0
9
34
2.65
1.86
1.8
1.5
—
—
—
0
0
1721
16790
1.19
1.85
30.3
11.3
23.81
25.13
u/l
4.20
1694
16077
21
115
1.83
1.83
1.1
1.1
—
—
—
0
0
48
327
1.48
1.82
1.2
1.1
—
—
—
0
0
40
262
1.54
1.82
1.2
1.1
—
—
—
0
0
1504
14540
1.14
1.77
5.4
4.9
2.13
2.10
mu/l
0.14
1406
12999
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
95
1.90
1.75
1.2
1.1
—
—
—
0
0
8
30
2.67
1.72
1.9
1.2
—
—
—
0
0
461
5091
0.88
1.71
4.0
4.7
21.05
21.62
%
0.35
221
2668
145
1185
1.24
1.69
9.4
8.7
93.73
93.74
%
0.00
145
1177
237
2036
1.19
1.67
2.7
4.1
24.13
20.94
ug/l
0.10
190
1691
17
90
1.90
1.65
1.2
1.4
—
—
—
0
0
60
436
1.39
1.64
6.8
7.4
104.91
105.49
mmol/l
0.49
54
393
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
17
91
1.88
1.60
1.1
1.1
—
—
—
0
0
16
84
1.91
1.59
1.4
1.1
—
—
—
0
0
147
1217
1.22
1.54
7.3
6.9
24.03
24.48
mmol/l
0.87
136
1138
13
64
2.04
1.54
38.8
25.1
135.08
124.51
ug/l
0.27
13
51
38
257
1.49
1.53
1.1
1.1
—
—
—
0
0
19
109
1.75
1.46
1.3
1.1
—
—
—
0
0
19
109
1.75
1.46
1.3
1.1
—
—
—
0
0
25
156
1.61
1.44
1.2
1.3
—
—
—
0
0
32
212
1.52
1.43
1.1
1.2
252.00
210.95
miu/ml
—
10
75
143
1191
1.22
1.43
9.4
8.5
1.42
1.34
%
0.57
143
1182
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
142
1185
1.21
1.40
9.6
8.6
0.68
0.68
%
0.02
142
1175
19
111
1.72
1.39
1.3
1.1
—
—
—
0
0
19
111
1.72
1.39
1.3
1.1
—
—
—
0
0
19
111
1.72
1.39
1.3
1.1
—
—
—
0
0
587
6315
0.90
1.36
5.0
5.4
5.38
3.98
ug/l
0.42
507
5579
26
395
0.65
1.36
6.2
3.9
36.09
29.16
mg/l
0.41
17
247
50
367
1.37
1.34
1.3
1.6
—
—
—
0
0
1576
15366
1.12
1.33
5.7
4.8
1.30
1.46
mmol/l
40.11
1483
13813
183
1578
1.18
1.28
2.0
2.1
266.72
147.14
ug/g
1.49
138
1236
1589
15517
1.12
1.24
5.8
4.8
4.11
4.53
mmol/l
47.15
1501
14069
21
131
1.61
1.23
1.3
1.1
—
—
—
0
0
53
399
1.34
1.23
1.2
1.2
5.04
7.48
u/ml
—
5
67
118
1409
0.83
1.22
1.5
1.7
1.48
1.55
%
0.70
96
1166
5
19
2.64
1.21
1.6
1.1
—
—
—
0
0
31
443
0.70
1.21
1.3
1.7
5040.86
13538.45
e6/l
3.64
22
322
78
624
1.26
1.17
1.4
1.2
—
—
—
0
0
27
183
1.48
1.13
1.0
1.1
—
17.22
—
0
6
14
80
1.76
1.13
1.9
1.6
8.19
10.58
ug/l
0.40
14
70
25
168
1.49
1.10
1.2
1.3
—
—
—
0
0
8
41
1.96
1.08
1.1
1.4
—
—
—
0
0
32
227
1.42
1.08
1.3
1.3
37.67
32.19
iu/l
0.45
27
194
16
97
1.65
1.06
2.2
2.4
—
—
—
0
0
5
23
2.18
0.98
1.4
1.2
—
—
—
0
0
31
225
1.38
0.94
1.6
1.8
165.32
207.02
pmol/l
1.46
31
210
31
226
1.38
0.92
1.3
1.3
16.46
10.65
u/l
1.40
26
178
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
63
515
1.23
0.84
1.4
1.5
298.12
277.12
ug/g
0.44
34
315
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
9
150
0.60
0.78
1.3
1.2
1.35
1.34
nmol/l
—
9
130
8
48
1.67
0.78
1.0
1.1
—
—
—
0
0
59
487
1.22
0.74
2.9
3.2
0.78
0.82
nmol/l
0.41
44
383
7
38
1.84
0.73
1.0
1.1
—
—
—
0
0
7
39
1.80
0.72
1.1
1.1
—
6.68
—
0
5
45
362
1.25
0.72
1.2
1.1
0.78
8.23
u/ml
—
5
23
5
27
1.85
0.68
1.6
1.0
—
—
—
0
0
11
69
1.60
0.68
1.6
1.5
—
—
—
0
0
7
44
1.59
0.65
1.1
1.3
—
—
—
0
0
7
44
1.59
0.65
1.0
1.3
7.96
9.31
ug/l
—
7
44
54
450
1.21
0.64
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
8
53
1.51
0.58
1.0
2.0
21.30
170.25
ug/l
—
8
46
13
90
1.45
0.55
1.1
1.1
—
—
—
0
0
334
3534
0.93
0.54
4.5
4.5
1.02
1.02
kg/l
0.04
43
549
13
91
1.43
0.53
1.1
1.5
0.93
0.95
g/l
0.07
13
91
46
387
1.19
0.52
1.7
2.7
33.00
35.05
umol/l
0.20
37
316
56
649
0.86
0.51
1.0
1.0
—
—
—
0
0
105
945
1.12
0.50
3.3
3.1
24.47
25.28
mmol/l
1.36
99
915
377
3961
0.94
0.50
1.6
1.8
35667187.46
14846369.44
pmol/l
0.25
300
3213
29
356
0.81
0.49
1.2
1.3
—
—
—
0
0
128
1170
1.10
0.46
3.2
3.0
120.97
127.25
g/l
2.08
120
1138
15
112
1.34
0.44
1.5
1.9
—
—
—
0
0
42
491
0.85
0.44
1.2
1.4
—
—
—
0
0
7
51
1.37
0.44
1.4
1.1
—
—
—
0
0
5
31
1.61
0.43
1.4
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
9.46
—
0
11
20
160
1.25
0.38
2.1
2.3
582.40
618.93
ml
—
10
105
5
36
1.39
0.38
1.8
2.0
1.15
1.20
mmol/l
—
5
36
12
89
1.35
0.38
1.0
1.0
—
—
—
0
0
17
213
0.80
0.36
1.2
1.6
64.82
63.82
%
0.03
11
136
7
52
1.35
0.31
1.4
1.1
—
—
—
0
0
1494
15082
0.96
0.30
6.1
6.5
37.44
40.74
mmol/mol
45.43
1405
13707
1605
15919
1.04
0.30
6.3
5.4
2.33
2.63
mmol/l
35.79
1514
14341
318
3061
1.05
0.30
1.2
1.2
2.52
1.50
u/ml
0.24
43
765
113
1054
1.08
0.30
2.2
2.1
11.85
12.63
nmol/l
0.42
95
914
7
57
1.23
0.29
1.4
1.1
—
—
—
0
0
7
57
1.23
0.29
1.1
1.2
154.77
280.61
iu/ml
—
7
57
24
278
0.86
0.26
1.3
1.4
—
—
—
0
0
17
142
1.20
0.24
2.2
1.4
—
—
—
0
0
5
39
1.28
0.23
2.8
2.9
14.78
14.80
ml/dl
—
5
34
10
79
1.27
0.22
1.2
1.4
0.27
0.22
nmol/l
—
5
60
5
41
1.22
0.22
1.2
1.2
103.60
110.09
%
—
5
35
0
10
0.00
0.21
0.0
1.3
—
2.60
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
4059.29
—
0
7
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
17.00
—
0
8
0
13
0.00
0.21
0.0
1.5
—
24.10
—
0
5
44
480
0.91
0.20
1.4
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
11
90
1.22
0.19
1.2
1.4
1.54
1.05
nmol/l
—
6
68
6
53
1.13
0.18
1.5
1.1
—
—
—
0
0
238
2453
0.97
0.18
1.2
1.2
15.90
14.59
u/ml
0.09
70
858
169
1751
0.96
0.17
2.4
2.5
4.34
7.02
ug/l
3.51
136
1525
44
407
1.08
0.17
1.9
3.3
943.60
1011.58
u/ml
0.03
37
380
232
2258
1.03
0.15
5.1
4.8
31.55
33.23
%
1.73
171
1443
36
332
1.09
0.15
1.8
1.6
—
—
—
0
0
37
342
1.08
0.15
1.2
1.4
522.17
624.15
e6/l
0.08
29
279
37
342
1.08
0.15
1.2
1.3
18.39
37.72
e6/l
0.42
28
263
20
180
1.11
0.13
2.0
1.5
—
—
—
0
0
186
1814
1.03
0.12
1.4
1.4
—
—
—
0
0
11
95
1.16
0.11
1.5
1.2
0.68
0.62
u/ml
—
5
49
80
831
0.96
0.11
1.2
1.2
95.40
136.11
iu/ml
0.71
27
305
5
48
1.04
0.09
1.0
1.1
2208.80
1513.13
miu/ml
—
5
48
434
4391
0.99
0.09
1.7
1.6
1.55
1.34
mmol/l
1.84
381
3613
226
2299
0.98
0.08
9.6
7.7
—
—
—
0
0
6
57
1.05
0.08
4.8
2.6
—
—
—
0
0
6
57
1.05
0.08
4.8
2.6
—
—
—
0
0
6
58
1.03
0.08
1.5
1.1
—
—
—
0
0
5
63
0.79
0.08
1.6
1.3
—
—
—
0
0
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
19
204
0.93
0.07
1.5
1.4
—
—
—
0
0
1571
15670
1.01
0.07
5.3
5.1
5.94
6.07
mmol/l
4.09
1431
13979
1728
17248
1.01
0.06
58.1
24.4
4.12
4.41
e12/l
44.09
1707
16657
250
2531
0.99
0.06
1.3
1.3
38.30
38.00
iu/ml
0.01
88
822
1728
17250
1.01
0.06
58.5
24.5
127.75
133.39
g/l
39.17
1716
16924
1728
17251
1.01
0.05
58.2
24.4
9.30
6.80
e9/l
24.74
1708
16661
1727
17245
1.01
0.04
58.3
24.4
380.31
242.64
e9/l
180.77
1711
16718
15
141
1.06
0.03
1.0
1.1
—
56.85
—
0
13
52
531
0.98
0.03
1.4
1.6
—
—
—
0
0
78
788
0.99
0.01
1.3
1.2
58.00
193.42
u/ml
7.73
64
719
16
154
1.04
0.00
1.1
1.0
3.72
2.37
u/ml
—
5
45
33
336
0.98
0.00
1.2
1.8
3.07
4.99
iu/l
—
10
100
47
464
1.01
0.00
2.8
2.3
113.51
92.62
ug/min
0.21
26
276
15
151
0.99
0.00
1.7
2.2
3.80
2.02
u/field
—
10
52
172
1715
1.00
0.00
1.4
1.3
—
—
—
0
0
13
132
0.98
0.00
1.0
1.1
—
5.17
—
0
6
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
91
0.99
0.00
5.9
3.6
13.91
13.23
%
—
9
91
0
5
0.00
0.00
0.0
8.0
—
74.80
—
0
5
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
7.61
—
0
7
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
9
96
0.94
0.00
1.8
1.2
—
—
—
0
0
9
97
0.93
0.00
1.8
1.2
—
—
—
0
0
8
80
1.00
0.00
1.5
1.2
304.87
440.19
u/l
—
8
74
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).